Viewing Study NCT03853993


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2026-03-02 @ 4:11 AM
Study NCT ID: NCT03853993
Status: COMPLETED
Last Update Posted: 2019-02-27
First Post: 2019-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)
Sponsor: Sinovac Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module